ANI PHARMACEUTICALS INC. - COMMON STOCK

ANI Pharmaceuticals Announces FDA Approval and Commercial Availability of New 1-mL Vial Size of Purified Cortrophin® Gel, Appropriate for Adjunctive Treatment of Certain Patients with Acute Gouty Arthritis Flares

02 10 2023 05:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023

18 9 2023 15:05:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP

12 9 2023 05:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1%

28 8 2023 05:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

24 8 2023 05:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors

23 8 2023 05:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals Reports Record Second Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance  

09 8 2023 05:50:31 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Discuss Second Quarter 2023 Financial Results on August 9, 2023, at 8:30 a.m. ET

31 7 2023 06:17:19 提供 Nasdaq GlobeNewswire